Tin tức & Cập nhật

Aficamten improves clinical outcomes in obstructive HCM
Aficamten improves clinical outcomes in obstructive HCM
30 Oct 2024 bởiStephen Padilla

Patients with obstructive hypertrophic cardiomyopathy (oHCM) can derive broad clinical benefits from treatment with aficamten, which include complete haemodynamic response and improved exercise capacity among others, as shown by the results of the SEQUOIA-HCM study.

Aficamten improves clinical outcomes in obstructive HCM
30 Oct 2024
Door-to-balloon time can be more lenient in STEMI not complicated by cardiogenic shock
Door-to-balloon time can be more lenient in STEMI not complicated by cardiogenic shock
30 Oct 2024
Beta blocker adjustment shows no impact on tachyarrhythmias in admitted HFrEF patients
Beta blocker adjustment shows no impact on tachyarrhythmias in admitted HFrEF patients
29 Oct 2024